Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Targeting liquid-liquid phase separation of SARS-CoV-2 nucleocapsid protein promotes innate antiviral immunity by elevating MAVS activity

Class:IdLiteratureReference:9755753
_displayNameTargeting liquid-liquid phase separation of SARS-CoV-2 nucleocapsid protein promotes innate antiviral immunity by elevating MAVS activity
_timestamp2021-10-11 05:49:52
author[Person:8863344] Wang, Shuai
[Person:9755759] Dai, Tong
[Person:9755735] Qin, Ziran
[Person:9683267] Pan, Ting
[Person:9755728] Chu, Feng
[Person:9755754] Lou, Lingfeng
[Person:3009205] Zhang, Long
[Person:5626895] Yang, Bing
[Person:9755730] Huang, Huizhe
[Person:9755750] Lu, Huasong
[Person:9755738] Zhou, Fangfang
created[InstanceEdit:9755755] Shamovsky, Veronica, 2021-10-11
journalNat Cell Biol
pages718-732
pubMedIdentifier34239064
titleTargeting liquid-liquid phase separation of SARS-CoV-2 nucleocapsid protein promotes innate antiviral immunity by elevating MAVS activity
volume23
year2021
(literatureReference)[Reaction:9694455] SUMO-p-N protein dimer binds genomic RNA [Homo sapiens]
[Reaction:9755747] SARS-CoV-2 N binds MAVS [Homo sapiens]
[Reaction:9756494] CREBBP acetylates SARS-CoV-2 N at K375 [Homo sapiens]
[Complex:9755729] N:MAVS [cytosol] [Homo sapiens]
[EntityWithAccessionedSequence:9756489] SUMO1-K62,ADPr-,p-11S,2T,met-R95,177,Ac-K375-N [cytosol] [Severe acute respiratory syndrome coronavirus 2]
[RegulationReference:9756488] Negative regulation by 'SUMO1-K62,ADPr-,p-11S,2T,met-2R,Ac-K375-N dimer [cytosol]' Targeting liquid-liquid phase separation of SARS-CoV-2 nucleocapsid protein promotes innate antiviral immunity by elevating MAVS activity
[CatalystActivityReference:9756498] peptide-lysine-N-acetyltransferase activity of CREBBP [cytosol] Targeting liquid-liquid phase separation of SARS-CoV-2 nucleocapsid protein promotes innate antiviral immunity by elevating MAVS activity
[Summation:9755752] SARS-CoV-2 nucleocapsid protein (N) can undergo liquid-liqui...
[Summation:9756241] Viral RNA binding to SARS-CoV-2 nucleocapsid protein (N) ind...
[Summation:9756251] Several studies showed that viral RNA binding to SARS-CoV-2 ...
List all 11 refering instances
[Change default viewing format]
No pathways have been reviewed or authored by Targeting liquid-liquid phase separation of SARS-CoV-2 nucleocapsid protein promotes innate antiviral immunity by elevating MAVS activity (9755753)